Abstract
Nicotine oxidoreductase (NicA2), a member of the flavin-containing amine oxidase family, is of medical relevance as it shows potential as a therapeutic to aid cessation of smoking due to its ability to oxidize nicotine into a non-psychoactive metabolite. However, the use of NicA2 in this capacity is stymied by its dismal O2-dependent activity. Unlike other enzymes in the amine oxidase family, NicA2 reacts very slowly with O2, severely limiting its nicotine-degrading activity. Instead of using O2 as an oxidant, we discovered that NicA2 donates electrons to a cytochrome c, which means that NicA2 is actually a dehydrogenase. This is surprising, as enzymes of the flavin-containing amine oxidase family were invariably thought to use O2 as an electron acceptor. Our findings establish new perspectives for engineering this potentially useful therapeutic and prompt a reconsideration of the term “oxidase” in referring to members of the flavin-containing amine “oxidase” family.
Introduction
Flavin-dependent enzymes most often utilize their flavin adenine dinucleotide (FAD) or flavin mononucleotide cofactors to conduct reduction-oxidation chemistry. These enzymes are able to pass electrons between their cofactor and substrate in one or two-electron transfer reactions1. Some flavoenzymes, termed oxidases, rapidly deliver electrons to molecular oxygen (O2), creating reactive oxygen species such as superoxide or hydrogen peroxide as a byproduct. Other flavoenzymes are more discerning, instead donating electrons to specific proteins or small molecule substrates. These enzymes are defined as dehydrogenases and generally do not react rapidly with O2. However, some degree of oxygen reactivity is inevitable in most flavin-dependent enzymes that form the flavin hydroquinone state due to the ~1 V reduction potential difference between flavins and O2. Flavin-containing amine oxidases (pfam:01593)2 are rapidly re-oxidized by O2 after accepting electrons from their amine-containing substrates. This rapid re-oxidation is evident, at least in vitro, for nearly all previously characterized members of this enzyme family3–5. Nicotine oxidoreductase (NicA2), however, appears to defy this convention, reacting with oxygen very slowly.
NicA2 is a FAD-dependent enzyme that catalyzes the oxidation of nicotine into N-methylmyosmine6. It was isolated from Pseudomonas putida S16, an unusual microorganism that can achieve robust growth using nicotine as its sole carbon and nitrogen source7. NicA2 catalyzes the first step in the catabolic pathway, which eventually results in the production of fumarate for primary metabolism8. NicA2’s FAD cofactor accepts a hydride from nicotine, converting it into N-methylmyosmine in the enzyme’s biologically important reductive half-reaction9. N-methylmyosmine then undergoes spontaneous hydrolysis to pseudooxynicotine, which is non-toxic and non-addictive in animal models10. Because of this, NicA2 has recently received attention as a potential therapeutic for treating nicotine dependence10–13. Two recent studies revealed that injection of NicA2 into nicotine-dependent rats largely eliminated nicotine from the blood, reversed symptoms of nicotine withdrawal, and dramatically reduced compulsive nicotine consumption and susceptibility to relapse11,13.
NicA2 receives two electrons from nicotine. In order to function as a catalyst, the two electrons retained on NicA2’s FAD from nicotine oxidation must be transferred to an electron acceptor. Given NicA2’s homology to flavin-dependent amine oxidases that transfer their electrons directly to O2, studies to date have assumed that O2 directly accepts the electrons from NicA2’s reduced FAD9,12. However, NicA2 has a turnover number of 0.007 s−1 when using O2 as a terminal electron acceptor10,14,15, an abysmally low number when compared with other flavin-containing amine oxidases which have turnover numbers of ~10–100 s−1 16–18. NicA2’s poor activity as an oxidase is an obstacle in developing this enzyme for nicotine cessation therapy. The low catalytic activity of the enzyme requires prohibitively large doses of NicA2, up to 70 mg kg−1, to achieve symptomatic relief of nicotine-dependent behavior in rats11. A previous study suggested that NicA2 may use a more effective electron acceptor, but did not propose any specific candidates14.
Here, we demonstrate that a novel cytochrome c protein, dubbed CycN, is responsible for accepting electrons from reduced NicA2 in vivo, not O2. Our results open up new avenues for using NicA2 in treating nicotine dependence and suggest that other flavin-dependent amine oxidases may also use alternative physiologic electron acceptors.
Results
NicA2 reacts poorly with O2.
The flavin cofactor contained in the nicotine-degrading enzyme NicA2 provides a convenient spectrophotometric readout for NicA2’s oxidation status1. In the absence of nicotine, NicA2 has an absorbance spectrum typical for oxidized FAD (Fig. 1a). Upon the addition of nicotine to NicA2, however, a clear reduction of FAD to the two-electron reduced hydroquinone (FADH2) was seen. NicA2’s flavin remained in the FADH2 state for several minutes before slowly re-oxidizing directly to oxidized FAD. This slow re-oxidation of NicA2 in the presence of oxygen suggests that flavin re-oxidation may be rate-limiting during O2-dependent turnover.
Figure 1 |. NicA2 is rapidly reduced by nicotine, but slowly re-oxidizes with O2.

a, NicA2 under ambient conditions was monitored by UV-vis spectrophotometry in the region of FAD absorbance. Upon addition of nicotine, rapid and complete reduction of FAD was observed and sustained for several minutes. NicA2-Flox, NicA2 containing oxidized FAD; NicA2-Flred, NicA2 containing FADH2. b, Oxidized NicA2 was combined with varying concentrations of nicotine and the change in absorbance at 450 nm was monitored by anaerobic stopped-flow spectrophotometry. Note the logarithmic timescale. The resulting traces required three exponentials to fit properly. Inset: plotting the kobs values of the three phases against the concentration of nicotine shows concentration independence. c, NicA2 was reduced by sodium dithionite titration under anaerobic conditions, then mixed with various concentrations of O2 and monitored for the change in FAD absorbance by stopped-flow spectrophotometry. Inset: a representative trace showing re-oxidation of NicA2’s FAD by 540 μM O2 at 450 nm. See Extended Data Figure 4a for traces at other O2 concentrations. These traces were well fit with a single exponential. d, The kobs values derived from fitting re-oxidation traces were plotted against the O2 concentration, demonstrating linear dependence. These experiments were independently repeated twice with similar results. Values reported are the mean ± s.e.m. of the fit.
Like most flavin-dependent enzymes, the catalytic cycle of NicA2 can be divided into two half-reactions. In the reductive half-reaction, NicA2 containing oxidized FAD (NicA2-Flox) is reduced by reacting with nicotine to form N-methylmyosmine. In the oxidative half-reaction, NicA2 containing FADH2 (NicA2-Flred) is oxidized by reacting with O2. To quantitatively determine the extent to which NicA2-Flred oxidation by O2 limits the consumption of nicotine by NicA2, we examined each half-reaction separately by performing stopped-flow experiments. Reduction of anaerobic NicA2-Flox by nicotine in the reductive half-reaction was extremely rapid (Fig. 1b). The observed rate constant (kobs) for each of the three phases observed did not change with increasing nicotine concentrations (Fig. 1b inset), suggesting that all three events occur after the bimolecular step in which nicotine first binds to NicA2-Flox. The first two phases (kobs of ~620 s−1 and ~130 s−1) contribute 95% of the signal change at 450 nm and have approximately the same amplitudes; the UV-vis spectra observed at the end of these two phases suggest that both correspond to FAD reduction by nicotine (Extended Data Fig. 1a). That there are two phases may indicate that the two active sites of the NicA2 dimer may be reduced by nicotine with discrete rate constants (Extended Data Fig. 2). The change in UV-vis spectrum for the final phase (kobs of ~6.6 s−1) is consistent with a ligand exchange event following FAD reduction by nicotine. This phase may represent exchange of N-methylmyosmine product with the available excess nicotine. Traces at all nicotine concentrations extrapolated back to the absorbance of NicA2-Flox at time zero (Extended Data Fig. 1b). Notably, the reductive half-reaction is completed within 1 s. That kobs for all three phases did not increase as the nicotine concentration was raised indicates that nicotine concentrations used were saturating and suggests that nicotine binds rapidly prior to FAD reduction. To further assess the possibility of rapid substrate binding, we measured binding kinetics using the non-catalytic nicotine analog myosmine. Myosmine binding was completed within the 1 ms dead time of the instrument at all myosmine concentrations (Extended Data Fig. 3), indicating that myosmine binds to NicA2-Flox with a kobs substantially greater than the rate constant for FAD reduction by nicotine.
We next monitored the reaction of NicA2-Flred with O2 in the oxidative half-reaction. NicA2-Flred was prepared by titrating NicA2-Flox with one equivalent of dithionite. The use of dithionite as a reductant enabled us to study the oxidative half-reaction in the absence of nicotine reaction products. During the dithionite titration, NicA2’s FAD first populated a form with a UV-vis spectrum resembling a neutral flavin semiquinone19 before reaching the fully reduced FADH2 state (Extended Data Fig. 1c). This suggests that NicA2 is capable of stabilizing a one-electron reduced flavin. Once fully reduced, NicA2-Flred was then mixed with buffer equilibrated with various O2/N2 ratios to re-oxidize NicA2’s flavin. Flavin re-oxidation by O2 was dramatically slower than the reductive half-reaction with nicotine, taking ~400 s for re-oxidation at 540 μM O2 (Extended Data Fig. 4a). NicA2-Flred oxidized directly into NicA2-Flox (Fig. 1c). Kinetic traces at 450 nm could be fit with a single exponential and the kobs for this phase increased linearly with O2 concentration (Fig. 1c inset and 1d), indicating that O2 directly oxidizes NicA2-Flred into NicA2-Flox in a bimolecular reaction. Linear fitting of kobs against [O2] yielded a bimolecular rate constant for flavin oxidation (koxO2) of 27 ± 1 M−1s−1. We also measured koxO2 for NicA2 reduced with one equivalent of nicotine instead of dithionite to test if the presence of the N-methylmyosmine product affects NicA2-Flred oxidation by O2. Titrating NicA2-Flox with one equivalent of nicotine produced a charge-transfer band from 500–700 nm as the FAD was reduced, indicating that the N-methylmyosmine product stays bound to NicA2-Flred after reduction (Extended Data Fig. 1d). N-methylmyosmine-bound NicA2-Flred was oxidized even slower by O2 than NicA2-Flred in the absence of N-methylmyosmine (Extended Data Fig. 4b,4c), with a koxO2 value of 5 ± 1 M−1s−1 (Extended Data Fig. 4d). Our data indicate that O2 is a poor electron acceptor for NicA2-Flred, particularly when compared to the koxO2 values of 105–106 M−1s−1 seen for most flavin-containing amine oxidases20.
Identification of NicA2’s physiological electron acceptor.
P. putida S16 is able to grow with a doubling time of about 90 min using nicotine as its sole carbon and nitrogen source7. At the established in vitro catalytic rate of NicA2 using O210, it is impossible to accumulate enough biomass from nicotine to sustain this doubling time. Even if 5% of P. putida S16’s biomass was made up of NicA2 enzyme, we calculate that this enzyme must have a catalytic rate of at least 1 s−1 in vivo to support a 90 min doubling time (see Online Methods). This implies that NicA2 uses a different electron acceptor in vivo.
The genome of P. putida S16 indicates a poorly annotated open reading frame (PPS_RS28240) just downstream of nicA2 (Fig. 2a)6,7,21. Both nicA2 and this open reading frame possess signal sequences for periplasmic localization (SignalP 5.022). A BLAST search of the downstream open reading frame revealed homology to cytochrome c proteins (Extended Data Fig. 5), and we therefore designate this gene as cycN. Cytochromes c are small electron carrier proteins that mediate electron transfer reactions, such as those between complex III and complex IV of the aerobic electron transport chain23. This, and the fact that cycN forms an operon with nicA2 led us to hypothesize that CycN plays a similar role for NicA2, shuttling electrons between NicA2 and the electron transport chain.
Figure 2 |. A cycN knockout is unable to grow on or degrade nicotine.

a, Top: The gene annotations when the genome of P. putida S16 was originally sequenced21. Bottom: The updated gene annotations currently available from NCBI show an uncharacterized cytochrome c-encoding gene WP_080563818.1 between nicA2 (PPS_RS28245) and pnao (PPS_RS21095), which we termed cycN (PPS_RS28240). b, Single colonies of P. putida S16 were streaked onto M9 salts agar supplemented with nicotine and imaged after two days of growth at 30 °C. The WT strain showed robust growth, whereas the ΔcycN strain grew poorly. Plasmid-based expression of cycN complemented the knockout. c, Quantitative western blots against NicA2 (green) in P. putida S16 lysates show expression of NicA2 as induced by nicotine in both the WT and ΔcycN strains over time. Purified NicA2 of known concentration was included as a loading control. d, Nicotine concentration as determined from cell culture by HPLC demonstrates decreasing concentration of nicotine over time in the WT strain, with no decrease in a ΔcycN strain. These experiments were independently repeated twice with similar results.
P. putida S16 ΔcycN is unable to grow on nicotine.
To test if CycN is NicA2’s physiological electron acceptor, an in-frame deletion of cycN was assessed for its ability to grow on nicotine24. Both the ΔcycN and wild-type (WT) strains grew well on rich media. When plated onto media where nicotine is the sole carbon and nitrogen source, the ΔcycN strain showed a growth defect (Fig. 2b). While WT P. putida S16 formed large, easily visible colonies within two days, the ΔcycN strain grew poorly. Presumably this is because in the absence of CycN, NicA2 is forced to use other electron acceptors such as O2, causing poor growth. The nicotine growth phenotype of the ΔcycN strain was complemented by plasmid-based expression of cycN (Fig. 2b), confirming that the growth deficiency is due to the loss of cycN. In vivo nicotine consumption experiments demonstrate that cycN is also necessary for NicA2’s ability to degrade nicotine (Fig. 2c,d). The NicA2 protein level is similar in WT and ΔcycN strains; however, while the WT strain consumed all the nicotine in the culture, the ΔcycN strain showed minimal nicotine consumption. This indicates that NicA2’s activity is dramatically reduced in the absence of CycN, in agreement with CycN being NicA2’s physiological electron acceptor. That nicotine is not degraded in ΔcycN strains makes it unlikely that any alternative oxidants make a physiologically important contribution toward re-oxidation of NicA2 in vivo.
CycN is reduced by NicA2.
Flavin-dependent dehydrogenases are known to transfer their electrons to a variety of small molecules and protein clients, including cytochromes c25,26. To further probe the relationship between NicA2 and CycN, we recombinantly expressed and purified both proteins from Escherichia coli to characterize their in vitro electron transfer activities. We used the spectral differences in the redox status for heme in cytochrome c27 as a readout to determine if NicA2 can transfer electrons from nicotine to CycN. Upon incubation of oxidized CycN with excess nicotine and a catalytic amount of NicA2, a characteristic shift of the Soret-banding pattern occurred, indicating that CycN had become reduced (Fig. 3). This reduction in CycN required both nicotine and NicA2. NicA2 also produces H2O2 when aerobically degrading nicotine in the absence of CycN, but not when CycN is provided (Extended Data Fig. 6a).
Figure 3 |. CycN is reduced by NicA2.

Oxidized CycN (dashed line) under ambient conditions was monitored by UV-vis spectrophotometry. Upon addition of 30 nM NicA2 and 100 μM nicotine, 3.75 μM CycN showed an increase in absorbance typical for reduced cytochrome c at 410 and 550 nm (solid line), indicating that CycN had become reduced. Arrows indicate the directionality of change. Both NicA2 and nicotine are required to produce this change, as adding either one individually failed to reduce CycN. This experiment was independently repeated twice with similar results.
NicA2-Flred is rapidly re-oxidized by CycN.
To measure the rate at which electrons are transferred from NicA2-Flred to oxidized CycN (CycNox) in vitro, we performed stopped-flow absorbance experiments by anaerobically mixing 15 μM NicA2-Flred with an excess of CycNox. Electron transfer between NicA2-Flred and CycNox was complete in less than 1 second. The absorbance changes were dominated by signals associated with reduction of CycNox’s heme from the Fe3+ to the Fe2+ state (CycNred) (Fig. 4a). We analyzed the kinetics of the reaction at 542 nm because the absorbance of CycNox and CycNred is identical at 542 nm so this readout is unaffected by changes in CycN’s oxidation state (Extended Data Fig. 7), and because NicA2’s flavin semiquinone (NicA2-FlSQ) absorbs at this wavelength, unlike NicA2-Flox and NicA2-Flred (Extended Data Fig. 1c). This wavelength therefore allowed us to monitor the expected transient formation of NicA2-FlSQ, since CycNox is an obligate one-electron acceptor and two CycNox molecules must react sequentially with NicA2-Flred in order to fully oxidize it back into NicA2-Flox. Kinetic traces of the reaction with more than a two-fold molar excess of CycNox indeed showed an increase, followed by a decrease in absorbance at 542 nm (Fig. 4a inset), in agreement with the formation of NicA2-FlSQ followed by its conversion to NicA2-Flox. We further tested that the signal changes at 542 nm report on NicA2-FlSQ by mixing NicA2-Flred with an equimolar amount of CycNox. Here we should only observe the increase at 542 nm, as there is only enough CycNox to react once on average with NicA2-Flred given that the first phase is substantially faster than the second. Reaction of 15 μM NicA2-Flred with 15 μM CycNox showed only an increase in absorbance at 542 nm without any subsequent decrease, confirming that we are observing formation of the NicA2-FlSQ at this wavelength (Extended Data Fig. 6b).
Figure 4 |. NicA2 is rapidly oxidized by CycN.

a, Oxidized CycN and reduced NicA2 were mixed in a series of anaerobic stopped-flow spectrophotometry experiments. Upon mixing, the absorbance changes were dominated by CycN reduction. Inset: The signal was monitored at 542 nm (an isosbestic point for CycN reduction/oxidation) in order to observe spectral changes only associated with NicA2 FAD absorbance. Note the logarithmic timescale. Traces at this wavelength fit well to two exponentials. See Extended Data Figure 9a for kinetic traces at all CycN concentrations. b, kobs values determined for the first phase were plotted against the concentration of CycN in each experiment, demonstrating linear dependence. The y-intercept was 6 ± 12 s−1. The kobs values for the second phase were also linearly dependent with CycN concentration. The negative y-intercept for kobs2 (–5.9±1.0 s−1) is likely a result of the CycN concentration for the second phase being lower than the initial CycN concentration since roughly one NicA2 equivalent worth of CycN is consumed in the first phase. c, the kobs values obtained for the reaction of oxidized CycN with N-methylmyosmine-bound NicA2 containing reduced FAD. The kobs values for both phases increased linearly with CycN concentration. The y-intercepts for kobs1 and kobs2 were −0.6 ± 0.3 s−1 and −2.2 ± 0.2 s−1, respectively. The large negative y-intercept for kobs2 was again likely due to the consumption of some CycN in the first phase. d, The apparent steady state turnover number for NicA2 using saturating nicotine (1 mM) and varying amounts of CycN. When fit by a line, the slope of the steady state data matched that of the second NicA2–CycN oxidation event for N-methylmyosmine-bound NicA2. Values reported are the mean ± s.e.m. of the fit for all panels. These experiments were independently repeated twice with similar results.
Stopped-flow traces at 542 nm using an excess of CycNox could be fit using a double exponential function. The kobs values for both phases increased linearly with the CycNox concentration, indicating that they both report on the bimolecular association of NicA2 with CycNox (NicA2-Flred and NicA2-FlSQ in the first and second phase, respectively). Linear fitting of the kobs plots yielded bimolecular rate constants (kon) of 1.0 ± 0.2 × 106 M−1s−1 and 2.7 ± 0.2 × 105 M−1s−1 for the first and second phase, respectively (Fig. 4b). Strikingly, these values are ~4–5 orders of magnitude greater than that for the oxidation of NicA2-Flred by O2 (which is 27 ± 1 M−1s−1). The fact that both phases are bimolecular indicates that electron transfer between CycNox and NicA2-Flred/SQ is rate-limited by association between the two proteins. Electron transfer between the two redox centers must therefore be extremely rapid after the complex has formed, and CycNred produced by the first electron transfer must dissociate from NicA2-FlSQ faster than the second CycNox binds (Extended Data Fig. 8). CycN does not form a stable complex with NicA2, in agreement with a large dissociation rate constant for the interaction (Extended Data Fig. 6c). Reaction traces at 552 nm, where the signal for CycNred formation dominates, also fit to two phases with kobs values similar to those obtained using the 542 nm data (Extended Data Fig. 9b), confirming that reduction of two CycNox molecules accompanies the two one-electron oxidations of NicA2’s flavin in the reaction.
We also monitored the kinetics of electron transfer between nicotine-reduced NicA2 and CycNox to see if the presence of the product, N-methylmyosmine, impacts electron transfer between the two proteins. Reaction traces again showed two kinetic phases, consistent with two stepwise one-electron transfers to two CycNox molecules required to fully oxidize N-methylmyosmine bound NicA2-Flred (Extended Data Fig. 9c,d). The kobs for both phases increased linearly with CycNox concentration, indicating that each phase still reports on the two different bimolecular association steps. Linear fitting of the two data sets yielded bimolecular rate constants of 1.4 ± 0.1 × 105 M−1s−1 and 7.7 ± 0.3 × 104 M−1s−1 for the first and second phase, respectively (Fig. 4c). Importantly, both of these values are more than 10,000-fold larger than the koxO2 of 5 M−1s−1 for oxidation of N-methylmyosmine-bound NicA2-Flred by O2, indicating that CycN is a much more effective oxidant for NicA2-Flred than O2 when N-methylmyosmine is bound.
Electron transfer to CycN limits turnover by NicA2.
We next used steady-state kinetic experiments of the NicA2-catalyzed electron transfer from nicotine to CycN to identify the rate-determining kinetic event. The reaction rate using saturating concentrations of nicotine increased linearly with CycN concentration over the accessible range of CycN concentrations (5–128 μM CycN). Presumably the reaction rate would saturate at higher CycN concentrations. Converting the rate data to apparent turnover numbers revealed that the apparent turnover number data was nearly identical to that of the second CycNox binding event for N-methylmyosmine-bound NicA2-Flred (Fig. 4d). This observation suggests that N-methylmyosmine remains bound to NicA2-Flred during electron transfer to CycNox and that binding of CycNox to NicA2-FlSQ is rate-determining at CycN concentrations ≤128 μM. This also suggests that the third phase in the reductive half-reaction with nicotine is not catalytically relevant since our measured apparent turnover numbers are larger than the kobs of ~6.6 s−1 for that step.
NicA2-Flred reacts poorly with bovine cytochrome c.
Is reactivity with NicA2 specific to CycN or will any cytochrome c work? Bovine cytochrome c (43% sequence identity to CycN), which is commonly used in the study of the electron transport chain, was tested as an electron acceptor for NicA2. It was not efficiently reduced, suggesting that NicA2 is specific for CycN (Extended Data Fig. 10a). Structural models of CycN indicate that the surface of bovine cytochrome c is enriched in positive charge relative to CycN, especially in the region near exposed heme (Extended Data Fig. 10b). Positively charged lysine residues are important for bovine cytochrome c binding to cytochrome oxidase28, so this difference in charge distribution between CycN and bovine cytochrome c may be partially responsible for NicA2’s specificity for CycN.
Discussion
We have demonstrated that a novel cytochrome c, CycN, is the physiological oxidant for NicA2, not O2. NicA2 is therefore a dehydrogenase, making it a notable outlier within the flavin-containing amine oxidase superfamily. We found that biphasic hydride transfer between nicotine and NicA2-Flox in the reductive half-reaction occurs rapidly. This is followed by a slower kinetic event that may correspond to dissociation of N-methylmyosmine. However, this slow step is unlikely to be relevant during turnover since our data suggest that N-methylmyosmine remains bound when NicA2 reacts with CycN. Re-oxidation of NicA2-Flred by CycN must occur in a sequence of two one-electron transfer reactions since each molecule of CycN can only receive one electron. Based on our data, both of these one-electron transfers appear to be rate-limited by the interaction between NicA2 and CycN; the subsequent electron transfer must be substantially faster than binding. These points are summarized in Figure 5. Oxidation of NicA2-Flred by O2 is unlikely to contribute substantially to nicotine turnover in vivo since O2 oxidizes NicA2-Flred with a rate constant ~10,000–15,000 times lower than its oxidation by CycN.
Figure 5 |. Proposed kinetic mechanism for the catalytic cycle of NicA2.

N-methylmyosmine (NMM) is the product resulting from the NicA2-catalyzed oxidation of nicotine. NicA2-Flox, NicA2 containing oxidized FAD; NicA2-Flred, NicA2 containing FADH2; NicA2-FlSQ, NicA2 containing a flavin semiquinone. Only the black path is relevant during catalytic turnover by the enzyme.
Our discovery that NicA2 is a dehydrogenase that uses CycN as an electron acceptor raises many interesting questions about how NicA2 discriminates between CycN and O2. NicA2 appears to be specific for CycN since bovine cytochrome c is a poor recipient of electrons from NicA2, suggesting that CycN contains structural features that optimize its reactivity or are important for binding to NicA2. Structures show that the isoalloxazine of NicA2’s FAD is buried within the protein core, >10 Å away from the surface. Can one-electron transfers between NicA2’s isoalloxazine and CycN’s heme span this distance, or are major conformational changes or protein-derived wires required for electron transfer between these redox centers? NicA2’s poor reactivity with O2 is also difficult to rationalize based on structures, as NicA2’s FAD binding site is very similar to that in a homologous protein that reacts rapidly with O2, namely 6-hydroxy-L-nicotine oxidase (Supplementary Fig. 1)29,30. Two recent studies attempted to screen NicA2 variants with residue mutations near the isoalloxazine or the presumed product exit site for improved O2-dependent nicotine-degrading activity12,31. However, NicA2 variants with only modest improvements were identified, suggesting that O2 reactivity in NicA2 is not controlled by structural features near the isoalloxazine. How reactivity with O2 is suppressed in NicA2 is thus currently unclear.
Microorganisms sometimes find ways to obtain energy and nutrients from surprising sources. For P. putida S16, CycN provides an illustration of one such adaptation. Rather than transferring electrons from nicotine directly to O2, which would waste valuable reducing equivalents and create H2O2, electrons are shuttled from NicA2 to CycN. Cytochrome c proteins are not known to be terminal electron acceptors. Thus, the electrons obtained by CycN from nicotine oxidation must be passed to another electron acceptor to enable continued turnover by NicA2. Where these electrons are transferred, and their eventual fate, is unknown. Other Pseudomonas subspecies conduct aerobic respiration using cytochrome c oxidases such as the cbb3 cytochrome oxidase of Pseudomonas aeruginosa32,33. Since P. putida S16 seems to contain similar machinery (Supplementary Fig. 2), this may provide an avenue for CycN re-oxidation. Regardless of the pathway that electrons take from CycN, CycN is clearly required for robust growth of the organism on nicotine.
Several recent studies have demonstrated NicA2’s potential utility as treatment for nicotine dependence10,11. One important caveat to these studies is the prohibitively large protein amounts required to achieve effective treatment—at least 10 and up to 70 mg kg−1 daily11, considerably more than is feasible for humans. Accordingly, there is interest in generating NicA2 variants with increased nicotine turnover rates. One avenue for enhancing therapeutic nicotine turnover suggested by our work is to co-administer CycN alongside NicA2. Another option would be to engineer NicA2 to enhance its oxidase activity. This may be possible given that NicA2 belongs to a family where most members react rapidly with O2. Site-saturation mutagenesis of NicA2’s active site12 enabled the identification of several mutations that allowed for an up to 19-fold increased turnover rate of nicotine with O2. These are relatively modest increases, given that NicA2 can re-oxidize at >10,000 times the rate of re-oxidation with O2 when provided its physiologic electron acceptor, implying that activity with O2 could perhaps be further improved.
Applying the lessons learned from NicA2 more generally, members of the flavin-dependent amine oxidase family are assumed to undergo oxidation by O2 in vivo and typically readily re-oxidize with O2 in vitro4. That NicA2 transfers electrons to a c-type cytochrome prompts reconsideration of this generalization and raises the possibility that other members of this family use alternative physiological oxidants. When amine oxidases use O2 as an oxidant, reactive oxygen species such as H2O2 are released as a byproduct34. It may therefore be more desirable to shunt electrons elsewhere in vivo, as we have shown occurs with NicA2 in P. putida S16. Furthermore, just because an amine oxidase is able to be rapidly oxidized by O2 in vitro does not necessarily mean that it uses O2 as its preferred electron acceptor in vivo. There is circumstantial evidence for the existence of one such example in human monoamine oxidases (MAOs) A and B35. These enzymes are bound to the outer mitochondrial membrane by a transmembrane tail anchor36–38. In their presumed catalytic cycle, MAOs are thought to be re-oxidized by O2, producing potentially damaging H2O239. Recent work, however, has demonstrated that human MAOs are not creating H2O2 as previously thought, and instead seem to transfer electrons from amine oxidation to complex IV of the electron transport chain35. Given that cytochrome c exists in the mitochondrial intermembrane space, we propose that cytochrome c may be the link facilitating electron transfer to the electron transport chain from MAOs. A re-evaluation of the mechanistic paradigm of these enzymes is indicated. MAOs are frequent targets for in vitro drug studies, and it may be that they are deprived of vital redox cofactors in these studies. Given the role of MAOs in neuropsychiatric disease, this topic warrants further consideration.
In summary, we have demonstrated that NicA2 is a flavin-dependent dehydrogenase that uses CycN as its redox partner. In the continued study of flavoenzymes, the “oxidase” paradigm for flavin-dependent amine oxidases should be reconsidered, as structural similarity alone clearly cannot determine oxygen reactivity.
Methods
Strains and culture conditions.
P. putida S16 was obtained from American Type Culture Collection (ATCC® BAA-2545™). Culture was performed in lysogeny broth (LB) media unless otherwise specified. M9 salts with nicotine media was made with the following: 6 g L−1 Na2HPO4, 3 g L−1 KH2PO4, 1 mM MgSO4, 0.1 mM CaCl2, 1 μg mL−1; thiamine, 1 g L−1 nicotine. M9 salts with nicotine agar was made with the same recipe, with an additional 15 g L−1 bacto agar (Thermo Fisher Scientific). All liquid cultures were inoculated from single colonies streaked out onto selective media. E. coli BL21 (DE3) cells were used for protein expression. Protein expression media (PEM) contains 12 g L−1 tryptone, 24 g L−1 yeast extract, 50.4 g L−1 glycerol, 2.13 g L−1 K2HPO4, and 12.54 g L−1 KH2PO4.
Construction of vectors.
Standard cloning techniques were used. pEC86 helper vector was obtained from the Culture Collection of Switzerland. pJN105 vector was obtained as a gift from Ute Römling (Karolinska Institute). Genes codon optimized for expression in E. coli were purchased from Genscript for cycN and nicA2 and cloned via restriction digest into pET28a, pJN105, or pET22b vectors. The nicA2 gene, including its N-terminal signal sequence, was cloned into pET28a containing an N-terminal His-SUMO tag. For the complementation experiments, full-length cycN, including its native signal sequence, was cloned into pJN105. For protein expression and purification, the sequence for mature cycN lacking its signal sequence was cloned downstream of the pelB leader sequence in pET22b.
Estimating NicA2 turnover rate in vivo.
When grown on nicotine as its sole carbon and nitrogen source, P. putida S16 obtains nearly all of its biomass from this metabolite. Using the known values for doubling time, bacterial mass, and the amount of nicotine that must be turned over to sustain growth, we can estimate the minimal nicotine turnover rate for NicA2. A single bacterium’s carbon and nitrogen content has a mass of ~0.3 pg, P. putida S16 doubles in roughly 90 min when grown on nicotine7, and nicotine has a molecular weight of 162 g mol−1. Therefore, each bacterium must turn over 2 × 10−15 mol of nicotine to double its mass. Assuming that NicA2 accounts for no more than 5% of total cell mass, there can be no more than 2.8 × 10−19 mol of NicA2 expressed for a single cell. We thus estimate the NicA2 in vivo turnover rate as 2 × 10−15 mol nicotine degraded by 2.8 × 10−19 mol NicA2 in 90 min, resulting in a turnover rate of ~1.3 s−1.
NicA2 expression and purification.
The pET28a-based expression vector for NicA2 was transformed into E. coli BL21 (DE3) cells and grown in 4 L PEM at 37 °C with shaking to an OD600 of 1.0. The temperature was then lowered to 20 °C and expression induced with 100 μM IPTG. The culture was grown overnight at 20 °C. After harvesting, the cells were lysed at 4 °C by sonication in 50 mM Tris HCl, 400 mM NaCl, 15 mM imidazole, 10% glycerol, pH 8.0 (lysis buffer) with DNase I and cOmplete™ protease inhibitor cocktail. The lysate was cleared by centrifugation and the supernatant was loaded on three 5 mL HisTrap columns pre-equilibrated in lysis buffer. The columns were washed with 20 mL lysis buffer, then 20 mL lysis buffer + 20 mM imidazole, and NicA2 was then eluted in lysis buffer + 0.5 M imidazole. NicA2 was then exchanged into 40 mM Tris-HCl, pH 8 + 0.2 M NaCl in the presence of protease ULP1 to cleave off the His-SUMO tag and subsequently passed over the HisTrap column again in 25 mM Tris HCl, pH 8 + 0.2 M NaCl to remove the His-SUMO tag. Protein was then exchanged into 25 mM Tris pH 8.5 and loaded onto three 5 mL HiTrap Q columns equilibrated into the same buffer. NicA2 was eluted by linear salt gradient using 25 mM Tris pH 8.5 + 1 M NaCl. Fractions containing NicA2 were concentrated, then run over a HiLoad Superdex 200 column in 40 mM HEPES 100 mM NaCl pH 7.4. Purified protein was concentrated and flash frozen, then stored at −80 °C until use (Supplementary Figure 3a).
CycN expression and purification.
The methods in enzymology subsection describing expression and purification of cytochromes c was followed40. Antibiotic selection was maintained with chloramphenicol 17 μg mL−1 and ampicillin 100 μg mL−1 throughout. All incubations were performed at 30 °C. E. coli BL21 (DE3) cells were transformed with both pEC86 helper vector and pET22b-cycN for periplasmic expression. A single colony of the resulting transformation was inoculated into overnight culture, then subcultured into 3L PEM and incubated at 200 rpm. Cultures were grown to a density of OD 0.6–0.8, then induced with 10 μM IPTG. Cells were left to express overnight for 18–22 h. Red pellets were visible after spinning down at 4,000g for 20 min.
Pellets were immediately resuspended for periplasmic extraction by osmotic shock in ice-cold osmotic shock buffer (0.5 M sucrose, 0.2 M Tris HCl, pH 8.0, and 0.5 mM EDTA), 50 mL buffer per L of culture. 33 mL ice-cold water was added after resuspension, and the resulting mixture was incubated on ice with gentle shaking for 2 h. Suspensions were spun down at 12,000 g for 20 min, and the red supernatant saved. These supernatants were dialyzed against 4 L of pH 4.0 30 mM sodium citrate + 38 mM Na2HPO4 overnight, then dialyzed into an additional 4 L of 25 mM NaH2PO4 at pH 4.0. The next day, samples were loaded onto a HiTrap SP HP cation exchange column (GE Life Sciences) equilibrated in the same buffer, and eluted against 25 mM NaH2PO4, pH 4.0 + 1 M NaCl in a salt gradient. Final cleanup was performed by running over a HiLoad Superdex 75 size exclusion column equilibrated in 40 mM HEPES 100 mM NaCl pH 7.4. Purified protein was flash frozen and stored at −80 °C until use (Supplementary Figure 3b).
Generation of cycN knockout.
A cycN knockout was generated by two-step allelic exchange according to the protocol established by Hmelo et al.24. Briefly, PCR of P. putida S16 genomic DNA was used to amplify regions upstream and downstream of cycN using the listed primers (Supplementary Table 1). CycN_del_down primers created a DNA fragment containing the stop codon, the last few amino acids for CycN, and ~500 bp of downstream sequence. CycN_del_up primers created a fragment with ~500 bp of upstream sequence, including the start codon and first few amino acids for CycN. An additional PCR reaction using the set of both products and the primers CycN_del_up_Fwd and CycN_del_down_Rev was used to assemble the fragments together, creating a substrate for homologous recombination against the P. putida S16 genome. This was cloned into pEX18-Gm vector by restriction digest. Upon recombining, the P. putida S16 homologous fragment will insert next to the cycN gene along with the pEX18-Gm sequence containing a gentamycin marker and sacB marker for sucrose counterselection. pEX18-Gm cannot replicate in P. putida S16, and gentamycin resistance can only be passed on in this strain by genomic integration. Therefore, by first selecting for gentamycin resistance, we generate clones with the integrated genomic marker. Then, counterselecting by plating onto sucrose afterward, we select for clones that undergo a secondary recombination event, removing remaining pEX18-Gm sequence with sacB and the majority of cycN coding sequence, resulting in a scarless knockout.
pEX18-Gm was electroporated into the mating strain E. coli S17. Both E. coli S17 and P. putida S16 strains were grown at 30 °C until an OD of 1.0 was reached, at which point 5 mL of culture was spun down and resuspended in 1 mL LB. An equal mixture of each strain, 200 μL each, was then spotted onto an LB agar plate for mating overnight at 30 °C. The next day, the spot was scraped and washed three times with 1 mL 150 mM NaCl. The resulting washed cells were resuspended in 500 μL 150 mM NaCl, and serial dilutions were plated on M9 salts + 0.4% glucose + 25 μg mL−1 gentamycin plates for selection of Pseudomonas with genomic integration of antibiotic marker. This resulted in >100 colonies, 8 of which were re-streaked onto 20% sucrose no-salt LB agar for secondary selection. This resulted in many single colonies, 16 of which were chosen for colony PCR screening using the listed CycN_verify primers, identifying which colonies successfully recombined cycN out. Three colonies appeared positive by size of PCR band; these were then gel extracted and submitted for Sanger sequencing, confirming the location and fidelity of knockouts.
Phenotyping wild-type, knockout, and complemented P. putida S16.
Single colonies of each strain grown from LB agar plates were streaked onto M9 salts + 1 mg mL−1 nicotine plates to examine for growth. Only the WT grew well on these plates. WT and ΔcycN strains were grown overnight in LB media and electroporated with pJN105 empty vector and pJN105-cycN for the complementation assay. These were plated onto LB + 25 μg mL−1 gentamycin selection plates. Single colonies from these plates were then streaked onto fresh plates containing M9 salts + 1 mg mL−1 nicotine additionally supplemented with 25 μg mL−1 gentamycin and 0.01% arabinose to observe for growth at 30 °C for 2–5 days.
In vitro assays.
The buffer used in all in vitro experiments was 40 mM HEPES-KOH, pH 7.5, 100 mM NaCl, 10% glycerol. NicA2 is in its fully oxidized form under ambient conditions in the absence of nicotine. The absorbance spectrum of oxidized FAD was used to determine the concentration of NicA2, using an extinction coefficient of 11,300 M−1 cm−1 at 450 nm. 20 μM NicA2 was combined with 40 μM nicotine and rapidly transferred to an absorbance cuvette to measure reduction of NicA2 under ambient conditions.
CycN was fully oxidized by addition of 5 mM ferricyanide. Excess ferricyanide was then exchanged out of the sample by running over a PD-10 desalting column before use. Concentrations of CycN were determined using the extinction coefficient of oxidized cytochrome c at 410 nm (101,600 M−1 cm−1). NicA2 and CycN were observed for characteristic spectrophotometric changes in a Shimadzu UV-1900 UV-vis spectrophotometer. 3.75 μM CycN was combined with either 100 μM nicotine alone, 30 nM NicA2 alone, or both together and monitored for change between 250–600 nm. The same assay was performed with bovine cytochrome c (Sigma-Aldrich), except that the concentration of bovine cytochrome c was 6.84 μM. It was monitored for change in absorbance in the same region (250–600 nm) for 15 min. Oxidized CycN was additionally titrated with increasing amounts of sodium dithionite to achieve a fully reduced state, with absorbance scans taken at each titration step.
Nicotine degradation assay.
This assay was performed to determine both the amount of nicotine degraded and the concentration of NicA2 enzyme in cultures of P. putida S16 grown in the presence of nicotine. Both wild-type and ΔcycN strains were grown overnight in LB. The next day, these cultures were diluted to OD 0.1 in 5 mL M9 salts + 0.4% glycerol and allowed to grow for 2 h. At this time point, nicotine was added to a final concentration of 1 mg mL−1 in each sample. The point of nicotine addition was considered time = 0. From then on, the cultures were sampled at 2, 4, 8,16, and 24 h. 200 μL of culture extracted at each time point was spun down at 16,000g for 10 min. The supernatant was isolated, and 100 μL supernatant was mixed with 300 μL methanol to prepare HPLC samples. The cell pellet was resuspended in 100 μL Bacterial Protein Extraction Reagent (B-PER; Thermo Fisher) and allowed to incubate at room temperature for 15 min to complete lysis. After this time had elapsed, 25 μL of 5x reducing gel loading buffer was added to each sample.
Samples for HPLC were further clarified by spinning at 16,000g for 30 min. 100 μL of each clarified sample was placed into autosampler vials. These were injected then separated for analysis using a Vydac C18 4.6×250 mm column (Catalog: 218TP54) and an isocratic water + 0.1% TFA mobile phase. A nicotine standard concentration gradient from 10 mM down to 1 μM was run. 10 μL of standards and experimental samples were injected for analysis. Samples and standards were within the linear range of detection, and the absorbance peaks were integrated for quantification.
Samples for western blot analysis were boiled for 5 min. Protein standards of purified NicA2 were prepared at known concentrations from 1 μM to 1 nM. 10 μL of each sample and standard were loaded onto a Bio-Rad 12% SDS-reducing gel and run at 150 V until completion. The gel was transferred to nitrocellulose blot via the Trans-Blot Turbo system (Bio-Rad). Blots were blocked in 5% milk TBST and stained with 1:10,000 rabbit-derived NicA2 antisera (Pacific Immunology) overnight at 4 °C. Blots were washed with 5% milk TBST three times, and then incubated with 1:20,000 goat anti-rabbit IR800 dye (LI-COR Biosciences) for 2 h at room temperature. Membranes were washed with TBST and then imaged using a LI-COR Odyssey Clx. Protein bands were quantified using LI-COR Odyssey software, and the NicA2 standard curve was used to determine the linear range of detection and concentration of NicA2 at each time point from the experiment.
Sedimentation velocity analytical ultracentrifugation (SV-AUC).
SV-AUC was carried out using 400 μl sample loaded into two-sector titanium centerpieces with 1.2 cm path-length in an An60Ti rotor in a Beckman Optima Xl-I analytical ultracentrifuge. Measurement was completed in intensity mode. All SV-AUC data were analyzed using UltraScan 4 software, version 4.0 and fitting procedures were completed on XSEDE clusters at the Texas Advanced Computing Center (Lonestar, Stampede) through the UltraScan Science Gateway (https://www.xsede.org/web/guest/gateways-listing)41. The partial specific volume (vbar) of NicA2 was estimated within UltraScan III based on the protein sequence42. Raw intensity data were converted to pseudo-absorbance by using the intensity of the air above the meniscus as a reference and edited. 2-dimensional sedimentation spectrum analysis (2DSA) was performed to subtract time-invariant noise and the meniscus was fit using ten points in a 0.05-cm range43. First arrays with a broad S range were fitted to account for possible large oligomeric states. Final arrays were fit using an S range 1–10, an f/f0 range of 1–4 with 64 grid points for each, 10 uniform grid repetitions and 400 simulation points. 2DSA was then repeated at the determined meniscus to fit radially invariant and time-invariant noise together using ten iterations. The 2DSA solution was refined by a genetic algorithm (GA), which uses an evolutionary based approach using random cross-over, mutations and deletion operations to alter the solute characteristics of the 2DSA solutes to eliminate false positive solutions44. The results from the genetic algorithm were evaluated using a Monte Carlo algorithm.
Transient kinetics.
All stopped-flow experiments were performed in 40 mM HEPES-KOH, pH 7.5, 100 mM NaCl, 10% glycerol at 4 °C. NicA2 and CycN solutions were made anaerobic in glass tonometers by repeated cycles with vacuum and anaerobic argon45. When needed, NicA2’s FAD was reduced in the anaerobic tonometer by titrating with a dithionite solution or anaerobic nicotine solution housed in a gas-tight Hamilton syringe. The dithionite or nicotine solutions were slowly added up to the point where NicA2’s flavin reached the fully-reduced hydroquinone state, and the redox status of the flavin was spectrophotometrically monitored during the titration using a Shimadzu UV-1900 UV-vis spectrophotometer (UV Probe software). Nicotine-containing buffer solutions were made anaerobic by sparging for at least 10 min with anaerobic argon. Buffer containing O2 at specific concentrations was prepared by sparging different O2/N2 gas ratios through buffer in a gas-tight syringe for at least 15 min at room temperature. The various O2/N2 gas ratios were prepared from O2 and N2 gas cylinders using a Maxtec MaxBlend 2 gas mixer, and the dissolved O2 concentration in the buffer solution was calculated using a Henry’s law constant for O2 of 770 atm M−1.
Stopped-flow experiments were conducted using a TgK Scientific SF-61DX2 KinetAsyst stopped-flow instrument (with Kinetic Studio software) that had been previously equilibrated with a glucose/glucose oxidase solution to make the internal components of the system anaerobic. ~30 μM NicA2 (flavin concentration before mixing) was loaded onto the instrument and mixed with substrate (nicotine, O2, or CycN) at a range of concentrations. The reactions were monitored either using the instrument’s multi-wavelength CCD detector (1.6 ms data interval time) or a single wavelength detector with photomultiplier tube. Kinetic traces were fit to sums of exponentials using KaleidaGraph (Synergy Software) to determine observed rate constants.
Steady state assays.
Anaerobic steady state assays were performed in a stopped-flow spectrophotometer in 40 mM HEPES-KOH, pH 7.5, 100 mM NaCl, 10% glycerol at 4 °C. NicA2 and nicotine were made anaerobic in a glass tonometer with the nicotine in a side arm separated from the NicA2 solution. After achieving anaerobiosis, the nicotine was added to the NicA2 solution, resulting in a solution containing 200 nM NicA2 (flavin concentration) and 2 mM nicotine. The NicA2/nicotine solution was then mixed with various concentrations (10–255 μM before mixing) of anaerobic, oxidized CycN and the reduction of CycN was observed at 550 nm over 80 s. The linear rate was obtained over the first 5 s of the reaction and 21,000 M−1cm−1 was used as the difference in extinction coefficient at 550 nm between reduced and oxidized CycN46.The rate data were divided by two since two CycN molecules are used in a single turnover by NicA2 and then divided by the NicA2 concentration (100 nM after mixing in the experiment) to obtain the apparent turnover number for each CycN concentration.
Amplex Red Assay.
For H2O2 detection, these assays were performed similarly to what has been previously reported for NicA29,15 following the recommendations provided in the Amplex Red Assay Kit (Thermo Fisher Scientific). Assays were performed in 40 mM HEPES-KOH, pH 7.5, 100 mM NaCl. Reactions were measured in a platereader with excitation wavelength of 530 nm and emission wavelength of 590 nm. Samples were combined to have end concentrations of the following constituents in a 100 μL reaction: 1 μM NicA2 (flavin concentration), 20 μM oxidized CycN, 10 μM nicotine, 0.1 units mL−1 horseradish peroxidase, 50 μM Amplex Red. These were mixed and immediately observed at room temperature in the plate reader for 30 min. A standard curve of H2O2 stock concentrations was used to determine the linear range of the assay and assign the concentration of H2O2 produced in each case.
Extended Data
Extended Data Fig. 1. Reduction of NicA2 by nicotine, absorbance traces and intermediates.

a, Oxidized NicA2 was rapidly mixed with 0.2 mM nicotine and absorption of its flavin cofactor monitored using a CCD detector. The two intermediates detectable in reaction traces at 450 nm were maximally populated at 3.2 and 300 ms, and the absorbance spectra at these two points is shown. b, Absorbance trace overlay at 450 nm from stopped-flow experiments where NicA2 was reduced by rapid mixing with various concentrations of nicotine. Traces at all nicotine concentrations extrapolated back to the absorbance of NicA2-Flox at time zero, indicating that no observable kinetic events were missed within the dead time of the stopped-flow instrument. Note the logarithmic timescale. c, Partial reduction of oxidized NicA2 with sodium dithionite produced a species with an increased absorbance from 525–650 nm. The spectrum of the titration point with the highest absorbance in this region is most consistent with a mixed population of oxidized flavin, flavin hydroquinone, and neutral flavin semiquinone19. Further titration with sodium dithionite resulted in complete reduction to the hydroquinone (FADH2) state. NicA2-Flox, NicA2 containing oxidized FAD; NicA2-Flred, NicA2 containing FADH2; NicA2-FlSQ, NicA2 containing flavin semiquinone. d, NicA2-Flox was reduced by titration of one molar equivalent of nicotine, resulting in reduction of the flavin cofactor as monitored by absorbance. Additionally, a charge transfer band developed in the region of 500–700nm over the course of the titration, likely indicating that at least some amount of N-methylmyosmine product remains bound to NicA2 after reduction of its flavin.
Extended Data Fig. 2. NicA2 is a dimer in solution.

Previous work has described NicA2 as a monomer using size exclusion chromatography14,15. To determine the quaternary structure of NicA2 in our buffer conditions, a solution of NicA2 at 20 μM (monomer concentration) was subjected to analysis by sedimentation velocity AUC at a rotor speed of 44,000 rpm while monitoring 450 nm. Data were analyzed using UltraScan 4, version 4.0. One species predominated in solution, with a sedimentation coefficient of ~5.45 and an apparent molecular weight of ~115 kDa. The expected molecular weight for the NicA2 monomer is 53.13 kDa, indicating that NicA2 is a homodimer in solution under these conditions. This experiment was independently repeated twice with similar results.
Extended Data Fig. 3. NicA2 rapidly forms a complex when titrated with the non-catalytic nicotine analogue myosmine.

a, Tryptophan fluorescence was used to quantify binding of myosmine as previously performed9. Traces from a stopped-flow experiment where oxidized NicA2 was mixed with varying concentrations of myosmine demonstrate a rapid binding event, occurring within the dead time (1 ms) of the instrument. b, Averaged fluorescence values of 5 traces per myosmine concentration were fit to determine the Kd for myosmine binding at 268 ± 3 μM (s.e.m.).
Extended Data Fig. 4. NicA2 is slowly re-oxidized by O2 in the presence and absence of N-methyl-myosmine.

a, Absorbance traces from stopped-flow experiments where NicA2, first reduced with dithionite, was then rapidly mixed with variable concentrations of O2. b, NicA2 was reduced with an equimolar amount of nicotine, and then rapidly mixed with O2 in a stopped-flow experiment which was monitored via the CCD detector. Inset: following the absorbance at 450nm over time in this experiment, re-oxidation was very slow, similar to the behavior of dithionite reduced NicA2. NMM-NicA2-Flox, N-methylmyosmine bound NicA2 containing oxidized flavin; NMM-NicA2-Flred, N-methylmyosmine bound NicA2 containing reduced flavin. c, Absorbance traces from stopped-flow experiments where NicA2, first reduced with nicotine, resulting in NMM-NicA2-Flred, was then rapidly mixed with variable concentrations of O2. d, kobs values for the re-oxidation of NMM-bound NicA2 were plotted against the concentration of O2, demonstrating linear dependence. e, The absorbance spectrum of NicA2-Flox (yellow) was compared in two conditions. In one case (red dashed line), nicotine was added to 40 μM end concentration, and the reaction allowed to proceed for 30 minutes until complete re-oxidation of the flavin. In the other case (black solid line) pseudooxynicotine was added to an end concentration of 40 μM and the spectrum taken immediately. NicA2-Flox, NicA2 containing oxidized flavin; PON, pseudooxynicotine. These experiments were independently repeated twice with similar results. Values reported are the mean ± s.e.m. of the fit.
Extended Data Fig. 5. CycN is most closely related to cytochromes from other nicotine degrading species.

CycN (highlighted in red) was used as the template for an NCBI BLAST homology search. The sequences with highest homology were collected, and identical sequences removed. A tree was generated using the NGPhylogeny web server with default settings48, then formatted into a figure using the Interactive Tree of Life (iTOL)49. Notably, the cytochrome c from Pseudomonas sp. HZN650 (highlighted in red) is not included in the NCBI database, but was added to the sequence set after manual review of that organisms genome. It appears that other known nicotine degrading organisms also contain cytochromes c similar to CycN, suggesting that they use a similar electron transfer pathway50,51. Sequence analyses of CycN related sequences was complicated by the fact that there is relatively poor annotation of these proteins in nicotine degrading organisms. For example, manual review of the pyrrolidine-pathway nicotine degrading bacteria Pseudomonas sp. HZN6 revealed an unannotated cytochrome c homologous protein just downstream of nicotine oxidoreductase. This is the same genomic architecture as for P. putida S16. This poor annotation led us to manually review other nicotine degrading organism’s genomes, in which we identify a consistent pattern. In organisms that use the pyrrolidine pathway, like P. putida S16, there are nicotine oxidoreductase enzymes similar to NicA2 with neighboring cytochrome c proteins. In those that metabolize nicotine via the pyridine pathway, there do not appear to be protein-based electron acceptors in the region of their nicotine degrading enzymes. For variant pyrrolidine/pyridine pathway (VPP) organisms, these do not appear to have cytochromes c, but often have pseudoazurin proteins in their nicotine degrading genomic islands. Pseudoazurins are able to participate in a range of electron transport reactions in the periplasm of bacteria52, though it is unclear if they could serve this role for flavin dependent amine oxidases in these organisms.
Extended Data Fig. 6. NicA2 and CycN’s interaction.

a, Oxidized NicA2 was incubated with nicotine under aerobic conditions in the presence (black filled circles) and absence (red filled circles) of oxidized CycN, and the amount of H2O2 produced by the reaction was monitored using the Amplex Red assay. Also included were conditions of NicA2 without nicotine (black empty circles) and with CycN but without nicotine (red empty circles). Only in the condition where NicA2 was incubated with nicotine in the absence of CycN was a significant amount of H2O2 produced. Three independent replicates were obtained and plotted. b, Oxidized CycN and reduced NicA2 were combined in an anaerobic stopped-flow spectrophotometer and observed for change in absorbance at 542 nm. When mixed in equimolar amounts (black points), absorbance rose and was maintained at an increased value indicating transition to the flavin semiquinone state. When mixed with excess CycN (blue points), NicA2 first reaches the semiquinone state (observable as an increase in absorbance) before becoming fully oxidized (observable as a subsequent decrease in absorbance. c, 40 μM CycN alone (black dashed line) or 40 μM CycN with 200 μM NicA2 (blue line) were run over a HiLoad Superdex 75 pg size exclusion column. CycN in the presence of excess NicA2 eluted with the same retention time as CycN alone and was well-resolved from the NicA2 peak. The insets show the absorbance spectrum of the two peaks in the chromatogram. Fractions 26 and 39 have spectra consistent with clean NicA2 and CycN, respectively, indicating that the two proteins do not bind with high affinity.
Extended Data Fig. 7. Reduction of CycN by dithionite.

UV-VIS spectra were recorded as sodium dithionite was serially titrated into a solution of oxidized CycN until it became fully reduced. Arrows represent the directionality of change during the titration. Inset: zooming in on just a small section of this titration, an isosbestic point is visible at 542 nm marked with an arrow. This wavelength was used to monitor the changes in absorbance for NicA2’s FAD in the experiments in Fig. 4.
Extended Data Fig. 8. Kinetic model for NicA2 oxidation by CycN.

In a two-step mechanism where rate-limiting CycNox binding to NicA2-Flred is followed by rapid electron transfer between the two redox centers, kobs should be linearly dependent on [CycNox] at low CycNox concentrations and should saturate at the sum of the rate constants for electron transfer (ke–forward + ke–reverse) at high CycNox concentrations53. Our data indicate that we have used CycNox concentrations at the low end of this concentration regime, where kobs increases linearly with CycNox concentration with a slope equal to kon for CycNox binding to NicA2-Flred. We presume that kobs would eventually reach a saturating value at high CycNox concentrations; however, we are not able to produce enough CycNox to explore the mM concentrations of CycNox that would be needed to achieve saturation. Notably, the rate constant for CycNox dissociation from NicA2-Flred (koff) should not contribute to the y-intercept of the kobs plot for the mechanism shown in this figure53. The kobs for the second phase also increased linearly with CycNox concentration, indicating that the above logic also applies for the reaction of the second CycNox with NicA2-FlSQ. This finding also indicates that CycNred resulting from the first one-electron transfer must dissociate from NicA2-FlSQ fast enough such that the second one-electron transfer event is also rate-limited by CycNox binding. In the kinetic scheme, the labels NicA2-Flred/SQ and NicA2-FlSQ/ox indicate that NicA2-Flred conversion to NicA2-FlSQ and NicA2-FlSQ conversion to NicA2-Flox are observed in the first and second phases, respectively.
Extended Data Fig. 9. CycN stopped-flow data.

a, Absorbance traces for the stopped flow reaction between ligand-free NicA2-Flred with variable concentrations of CycNox. In this case, the traces were able to capture formation and depletion of NicA2-FlSQ that occurred as the reaction proceeded. CycN contributes a substantial amount of absorbance at 542 nm. Accordingly, the traces were adjusted so that they all end at the same absorbance value to facilitate comparison. Note the logarithmic timescale. b, Signal change for the stopped-flow reaction was also monitored at 552 nm, a wavelength suitable for observing reduction of CycN. The trace required two exponentials (red curve) with similar amplitudes to fit properly, as one exponential (blue curve) was insufficient. Signal change occurred at the same time as NicA2 oxidation monitored at 542 nm, indicating that the processes occurred simultaneously. Note the logarithmic timescale. c, Signal change at 542 nm for the reaction of NMM-NicA2-Flred with CycNox. Curiously, traces at 542 nm, where NicA2-FlSQ is detectable, did not show the increase in absorbance that we observed with ligand-free NicA2-Flred; traces at this wavelength showed a decrease in absorbance that occurred in two phases, with the first phase contributing 80–90% of the total absorbance. This observation suggests that N-methylmyosmine in the active site inhibits NicA2’s FAD from populating a semiquinone state during the reaction with CycN. The decrease in absorbance at 542 nm may simply be due the small decrease in charge-transfer absorbance of N-methylmyosmine bound NicA2 that occurs when the flavin gets oxidized (Extended Data Fig. 4b). Reaction traces at 552 nm still showed the two kinetic phases with increasing absorbance (Extended Data Fig. 9b). Note the logarithmic timescale. d, Absorbance traces at 552 nm for the stopped flow reaction between NMM-NicA2-Flred and variable concentrations of CycNox. Traces fit best to two exponentials and the kobs values are reported in Fig. 4c of the main text. The traces were adjusted so that they all begin at the same absorbance value for comparison. Note the logarithmic timescale.
Extended Data Fig. 10. Bovine cytochrome c is not reduced by NicA2 and has different surface charge distribution than CycN.

a, Bovine cytochrome c combined with nicotine and NicA2 did not result in any reduction of the cytochrome c over 15 min of incubation, unlike the assay performed with CycN (Fig. 3). b, CycN was modeled onto the structure of bovine cytochrome c (PDB ID: 2B4Z) using the SWISS-MODEL online server54. Surface charge distribution of CycN and bovine cytochrome c was calculated using the APBS electrostatics plugin for PyMOL55. Bovine cytochrome c (top) is enriched for positive charge in the region where the heme is surface-exposed, whereas CycN (bottom) is closer to neutral/hydrophobic. Red color indicates negative charge density; blue color indicates positive charge density; heme cofactor is colored in magenta for both structures.
Supplementary Material
Acknowledgements
We thank Ben A. Meinen for performing the analytical ultracentrifugation experiments. This work was supported in part by a Western Michigan University Faculty Research and Creative Activities Award to F.S. J.C.A.B. is a HHMI investigator.
Footnotes
Competing financial interests
M.D., J.C.A.B., and F.S. are named on a provisional patent application partially based on the results of this work.
Data availability.
All data used in this study are included in this published article (and its supplementary information files) and are available from the corresponding authors upon reasonable request.
References
- 1.Massey V The chemical and biological versatility of riboflavin. Biochem. Soc. Trans 28, 283 (2000). [PubMed] [Google Scholar]
- 2.El-Gebali S et al. The Pfam protein families database in 2019. Nucleic Acids Res. 47, D427–D432 (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Tararina MA & Karen NA Bioinformatic analysis of the flavin-dependent amine oxidase superfamily: adaptations for substrate specificity and catalytic diversity. J. Mol. Biol 432, 3269–3288 (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Fitzpatrick PF Oxidation of amines by flavoproteins. Arch. Biochem. Biophys 493, 13–25 (2010). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Binda C, Mattevi A & Edmondson DE Structure-function relationships in flavoenzyme-dependent amine oxidations: a comparison of polyamine oxidase and monoamine oxidase. J. Biol. Chem 277, 23973–23976 (2002). [DOI] [PubMed] [Google Scholar]
- 6.Tang H et al. Novel nicotine oxidoreductase-encoding gene involved in nicotine degradation by pseudomonas putida strain S16. Appl. Environ. Microbiol 75, 772–778 (2009). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Tang H et al. Systematic unraveling of the unsolved pathway of nicotine degradation in pseudomonas. PLoS Genet. 9, e1003923 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Fitzpatrick PF The enzymes of microbial nicotine metabolism. Beilstein J. Org. Chem 14, 2295–2307 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Tararina MA et al. Crystallography coupled with kinetic analysis provides mechanistic underpinnings of a nicotine-degrading enzyme. Biochemistry 57, 3741–3751 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Xue S, Schlosburg JE & Janda KD A new strategy for smoking cessation: characterization of a bacterial enzyme for the degradation of nicotine. J. Am. Chem. Soc 137, 10136–10139 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Pentel PR et al. The nicotine-degrading enzyme NicA2 reduces nicotine levels in blood, nicotine distribution to brain, and nicotine discrimination and reinforcement in rats. BMC Biotechnol. 18, 1–14 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Thisted T et al. Optimization of a nicotine degrading enzyme for potential use in treatment of nicotine addiction. BMC Biotechnol. 19, 1–16 (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Kallupi M, Xue S, Zhou B, Janda KD & George O An enzymatic approach reverses nicotine dependence, decreases compulsive-like intake, and prevents relapse. Sci. Adv 4, eaat4751 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Tararina MA, Janda KD & Allen KN Structural analysis provides mechanistic insight into nicotine oxidoreductase from pseudomonas putida. Biochemistry 55, 6595–6598 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Xue S et al. An enzymatic advance in nicotine cessation therapy. Chem. Commun 54, 1686–1689 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Kopacz MM, Heuts DPHM & Fraaije MW Kinetic mechanism of putrescine oxidase from rhodococcus erythropolis. FEBS J. 281, 4384–4393 (2014). [DOI] [PubMed] [Google Scholar]
- 17.Vintém APB, Price NT, Silverman RB & Ramsay RR Mutation of surface cysteine 374 to alanine in monoamine oxidase A alters substrate turnover and inactivation by cyclopropylamines. Bioorganic Med. Chem 13, 3487–3495 (2005). [DOI] [PubMed] [Google Scholar]
- 18.Fitzpatrick PF, Chadegani F, Zhang S, Roberts KM & Hinck CS Mechanism of the flavoprotein l -hydroxynicotine oxidase: kinetic mechanism, substrate specificity, reaction product, and roles of active-site residues. Biochemistry 55, 697–703 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Su D, Kabir MP, Orozco-Gonzalez Y, Gozem S & Gadda G Fluorescence properties of flavin semiquinone radicals in nitronate monooxygenase. ChemBioChem 20, 1646–1652 (2019). [DOI] [PubMed] [Google Scholar]
- 20.Mattevi A To be or not to be an oxidase: challenging the oxygen reactivity of flavoenzymes. Trends Biochem. Sci 31, 276–283 (2006). [DOI] [PubMed] [Google Scholar]
- 21.Yu H et al. Complete genome sequence of the nicotine-degrading pseudomonas putida strain S16. J. Bacteriol 193, 5541–5542 (2011). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Almagro Armenteros JJ et al. SignalP 5.0 improves signal peptide predictions using deep neural networks. Nat. Biotechnol 37, 420–423 (2019). [DOI] [PubMed] [Google Scholar]
- 23.Lehninger AL, Nelson DL & Cox MM Lehninger Principles of Biochemistry. (W. H. Freeman, 2005). [Google Scholar]
- 24.Hmelo LR et al. Precision-engineering the pseudomonas aeruginosa genome with two-step allelic exchange. Nat. Protoc 10, 1820–1841 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Leferink NGH, Van Den Berg WAM & Van Berkel WJH L-Galactono-γ-lactone dehydrogenase from arabidopsis thaliana, a flavoprotein involved in vitamin C biosynthesis. FEBS J. 275, 713–726 (2008). [DOI] [PubMed] [Google Scholar]
- 26.Kuwahara T, White RA & Agosin M A cytosolic flavin-containing enzyme catalyzing reduction of cytochrome c in trypanosoma cruzi: kinetic studies with cytochrome c as substrate. Arch. Biochem. Biophys 241, 45–49 (1985). [DOI] [PubMed] [Google Scholar]
- 27.Butt WD & Keilen D Absorption spectra and some other properties of cytochrome c and of its compounds with ligands. Proc. R. Soc. Lond. B. Biol. Sci 156, 429–458 (1962). [DOI] [PubMed] [Google Scholar]
- 28.Döpner S et al. The structural and functional role of lysine residues in the binding domain of cytochrome c in the electron transfer to cytochrome c oxidase. Eur. J. Biochem 261, 379–391 (1999). [DOI] [PubMed] [Google Scholar]
- 29.Kachalova GS et al. Crystal structure analysis of free and substrate-bound 6-hydroxy-l-nicotine oxidase from arthrobacter nicotinovorans. J. Mol. Biol 396, 785–799 (2010). [DOI] [PubMed] [Google Scholar]
- 30.Fitzpatrick PF, Chadegani F, Zhang S & Dougherty V Mechanism of flavoprotein l-6-hydroxynicotine oxidase: pH and solvent isotope effects and identification of key active site residues. Biochemistry 56, 869–875 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Tang H et al. Molecular deceleration regulates toxicant release to prevent cell damage in Pseudomonas putida S16 (DSM 28022). MBio 11, 1–12 (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Arai H Regulation and function of versatile aerobic and anaerobic respiratory metabolism in pseudomonas aeruginosa. Front. Microbiol 2, 1–13 (2011). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Tribelli PM et al. Core regulon of the global anaerobic regulator Anr targets central metabolism functions in pseudomonas species. Sci. Rep 9, 1–13 (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Chaiyen P, Fraaije MW & Mattevi A The enigmatic reaction of flavins with oxygen. Trends Biochem. Sci 37, 373–380 (2012). [DOI] [PubMed] [Google Scholar]
- 35.Graves SM et al. Dopamine metabolism by a monoamine oxidase mitochondrial shuttle activates the electron transport chain. Nat. Neurosci 23, 15–20 (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Wang J & Edmondson DE Topological probes of monoamine oxidases A and B in rat liver mitochondria: Inhibition by TEMPO-substituted pargyline analogues and inactivation by proteolysis. Biochemistry 50, 2499–2505 (2011). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Zhuang Z, Marks B & McCauley RB The insertion of monoamine oxidase A into the outer membrane of rat liver mitochondria. J. Biol. Chem 267, 591–596 (1992). [PubMed] [Google Scholar]
- 38.Russell SM, Davey J & Mayer RJ The vectorial orientation of human monoamine oxidase in the mitochondrial outer membrane. Biochem. J 181, 7–14 (1979). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Gaweska H & Fitzpatrick PF Structures and mechanism of the monoamine oxidase family. 2, 365–377 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Londer YY Expression of recombinant cytochromes c in E. coli. Methods Mol. Biol 705, 123–150 (2011). [DOI] [PubMed] [Google Scholar]
- 41.Demeler B & Gorbet GE Analytical ultracentrifugation data analysis with UltraScan-III in Analytical Ultracentrifugation: Instrumentation, Software, and Applications (eds. Uchiyama S, Arisaka F, Stafford WF & Laue T) 119–143 (Springer; Japan, Tokyo, 2016). [Google Scholar]
- 42.Demeler B, Brookes E & Nagel-Steger LBT-M in E. Chapter 4 Analysis of heterogeneity in molecular weight and shape by analytical ultracentrifugation using parallel distributed computing in Computer Methods, Part A 454, 87–113 (Academic Press, 2009). [DOI] [PubMed] [Google Scholar]
- 43.Brookes E, Cao W & Demeler B A two-dimensional spectrum analysis for sedimentation velocity experiments of mixtures with heterogeneity in molecular weight and shape. Eur. Biophys. J 39, 405–414 (2010). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Brookes E & Demeler B Genetic algorithm optimization for obtaining accurate molecular weight distributions from sedimentation velocity experiments in Analytical Ultracentrifugation VIII 33–40 (Springer-Verlag, Berlin, 2006). [Google Scholar]
- 45.Moran GR Anaerobic methods for the transient-state study of flavoproteins: the use of specialized glassware to define the concentration of dioxygen. Methods Enzymol. 620, 27–49 (2019) [DOI] [PubMed] [Google Scholar]
- 46.Zabinski-Snopko RM & Czerlinski GH Spectrophotometric titrations of ferricytochrome c with ferrohexacyanide in the pH range 5 to 7. J. Biol. Phys 9, 155–167 (1981). [Google Scholar]
- 47.Su D, Kabir MP, Orozco-Gonzalez Y, Gozem S & Gadda G Fluorescence properties of flavin semiquinone radicals in nitronate monooxygenase. ChemBioChem 20, 1646–1652 (2019). [DOI] [PubMed] [Google Scholar]
- 48.Lemoine F et al. NGPhylogeny.fr: New generation phylogenetic services for non-specialists. Nucleic Acids Res. 47, W260–W265 (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Letunic I & Bork P Interactive Tree of Life (iTOL) v4: Recent updates and new developments. Nucleic Acids Res. 47, 256–259 (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Qiu J et al. Functional identification of two novel genes from Pseudomonas sp. Strain HZN6 involved in the catabolism of nicotine. Appl. Environ. Microbiol 78, 2154–2160 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Li J et al. Comparative genomics reveals specific genetic architectures in nicotine metabolism of Pseudomonas sp. JY-Q. Front. Microbiol 8, 1–11 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.De Rienzo F, Gabdoulline RR, Menziani MC & Wade RC Blue copper proteins: A comparative analysis of their molecular interaction properties. Protein Sci. 9, 1439–1454 (2000). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Bagshaw C Biomolecular Kinetics Ch 2.7: Two-step reversible binding reaction: inducted fit, 41–45 (CRC Press, Boca Raton, 2017). [Google Scholar]
- 54.Waterhouse A et al. SWISS-MODEL: Homology modelling of protein structures and complexes. Nucleic Acids Res. 46, W296–W303 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Jurrus E et al. Improvements to the APBS biomolecular solvation software suite. Protein Sci. 27, 112–128 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
